Reducing alcohol use and improving HIV treatment for men with pregnant partners in Uganda
Part of Immune system & allergy, Infections, Mental health clinical trials.
This study tests a program to help men living with HIV who drink heavily and have a pregnant partner. It aims to reduce alcohol use and improve HIV medication adherence to protect their partner and baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man living with HIV and have a pregnant partner who does not have HIV.
- You have been taking HIV medication for at least 6 months and recently had a detectable viral load or missed doses.
- You and your partner have lived together for more than 6 months and plan to stay together.
- You have your own mobile phone and can be reached by phone.
- You are not planning to move within the next 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether helping men with HIV who also drink heavily can lower their alcohol use and improve how well HIV treatment works to prevent passing the virus to others. It's for men living in fishing communities in Uganda.
This study tests a program to help pregnant women with HIV who also have depression, and their partners, reduce the risk of passing HIV to their babies. The program includes support for mental health and HIV care.
This trial aims to improve HIV prevention and treatment for pregnant adolescents and young women in Tanzania. It includes reviewing medical records, talking to patients and providers, and testing new care approaches.
This study tests a couples-focused program to help HIV-positive adolescent girls and young women stay connected to HIV clinic visits and medicines. It may help if you’re currently not well engaged in HIV care or you’ve faced partner violence or controlling behavior.
This study tests an HIV disclosure intervention—helping men living with HIV tell a sexual partner about their HIV status. It also involves partners (if invited) to support safer communication and care.
This research tests a tool that helps women and their partners make informed decisions about PrEP (a daily pill that prevents HIV). The study involves healthcare workers, patients, and leaders in Uganda to improve how women choose and use HIV prevention.
Hear when a new HIV Antiretroviral Therapy (ART) Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.